| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,249 |
37,122 |
$3.92M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
24,466 |
23,604 |
$2.54M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,711 |
13,174 |
$2.30M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,872 |
9,214 |
$1.59M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18,040 |
17,447 |
$1.26M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
19,078 |
7,000 |
$913K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,299 |
3,244 |
$889K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,391 |
4,123 |
$631K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
817 |
809 |
$566K |
| 87631 |
|
9,275 |
9,170 |
$505K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,664 |
1,634 |
$479K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,041 |
2,910 |
$444K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,364 |
2,335 |
$426K |
| 80053 |
Comprehensive metabolic panel |
25,067 |
22,368 |
$422K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,071 |
3,923 |
$310K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,822 |
11,438 |
$264K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
207 |
207 |
$260K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
830 |
821 |
$232K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,084 |
3,378 |
$209K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
967 |
808 |
$206K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
257 |
256 |
$182K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,737 |
2,736 |
$174K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,351 |
5,276 |
$162K |
| 97162 |
|
1,547 |
1,539 |
$160K |
| 76770 |
|
935 |
925 |
$150K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,353 |
5,280 |
$146K |
| 36415 |
Collection of venous blood by venipuncture |
24,493 |
17,855 |
$145K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,211 |
2,044 |
$134K |
| G0378 |
Hospital observation service, per hour |
512 |
440 |
$126K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
383 |
381 |
$124K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,674 |
3,595 |
$108K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,798 |
9,629 |
$106K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,291 |
4,162 |
$104K |
| 97161 |
|
1,184 |
1,183 |
$99K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,928 |
6,110 |
$99K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,564 |
2,546 |
$95K |
| 76801 |
|
1,687 |
1,533 |
$89K |
| 80061 |
Lipid panel |
7,273 |
7,230 |
$88K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,540 |
1,516 |
$87K |
| 76830 |
Ultrasound, transvaginal |
2,034 |
2,022 |
$85K |
| 84439 |
|
6,992 |
6,876 |
$83K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,073 |
1,069 |
$80K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,476 |
1,335 |
$80K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,991 |
1,884 |
$79K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
236 |
235 |
$71K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,492 |
2,470 |
$69K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
2,632 |
2,631 |
$69K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
196 |
196 |
$67K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,536 |
1,268 |
$64K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
207 |
207 |
$63K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,783 |
15,078 |
$61K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,084 |
2,083 |
$60K |
| 71046 |
Radiologic examination, chest; 2 views |
3,011 |
2,969 |
$56K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
987 |
974 |
$55K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,314 |
1,305 |
$51K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
347 |
308 |
$51K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,257 |
1,143 |
$50K |
| 86850 |
|
2,599 |
2,510 |
$48K |
| 87480 |
|
2,608 |
2,561 |
$44K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
975 |
965 |
$44K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,561 |
2,552 |
$43K |
| 87510 |
|
2,545 |
2,498 |
$43K |
| 59025 |
Fetal non-stress test |
770 |
516 |
$42K |
| 84702 |
|
2,317 |
1,562 |
$40K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,923 |
1,796 |
$39K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
377 |
377 |
$38K |
| 83880 |
|
1,142 |
1,101 |
$37K |
| 86803 |
|
2,726 |
2,713 |
$36K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
207 |
198 |
$36K |
| 87660 |
|
2,099 |
2,064 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,695 |
3,673 |
$31K |
| 86780 |
|
2,888 |
2,870 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,713 |
2,502 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,931 |
1,201 |
$31K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,021 |
4,850 |
$30K |
| 86901 |
|
2,656 |
2,545 |
$29K |
| 97535 |
Self-care/home management training, each 15 minutes |
760 |
618 |
$28K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,980 |
1,850 |
$27K |
| 82607 |
|
2,190 |
2,172 |
$27K |
| 87340 |
|
2,310 |
2,299 |
$25K |
| 82728 |
|
1,910 |
1,866 |
$25K |
| 86900 |
|
2,665 |
2,553 |
$25K |
| 85027 |
|
7,522 |
7,087 |
$24K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
915 |
584 |
$24K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,426 |
2,589 |
$23K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
490 |
487 |
$22K |
| 83655 |
|
1,496 |
1,487 |
$21K |
| 87081 |
|
4,960 |
4,897 |
$20K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
561 |
534 |
$19K |
| 76642 |
|
888 |
880 |
$19K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
27 |
26 |
$18K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,082 |
2,082 |
$17K |
| 90715 |
|
652 |
652 |
$16K |
| 71250 |
|
170 |
169 |
$16K |
| 0012A |
|
489 |
489 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,008 |
997 |
$15K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
24 |
24 |
$15K |
| 86787 |
|
1,084 |
1,077 |
$15K |
| 83735 |
|
2,262 |
1,692 |
$14K |
| 82784 |
|
993 |
981 |
$13K |
| 83970 |
|
259 |
247 |
$13K |
| 86762 |
|
1,276 |
1,269 |
$12K |
| 82043 |
|
882 |
872 |
$12K |
| 93971 |
|
120 |
119 |
$12K |
| 81025 |
|
3,286 |
3,224 |
$11K |
| 97113 |
|
252 |
99 |
$11K |
| 83550 |
|
1,139 |
1,116 |
$11K |
| 0011A |
|
511 |
511 |
$11K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
36 |
36 |
$11K |
| 71271 |
|
490 |
490 |
$11K |
| 84403 |
|
342 |
337 |
$11K |
| 82570 |
|
1,942 |
1,814 |
$10K |
| 86140 |
|
2,442 |
2,320 |
$10K |
| 74018 |
|
726 |
706 |
$10K |
| 97165 |
|
129 |
129 |
$10K |
| 80306 |
|
1,115 |
1,100 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
497 |
484 |
$10K |
| 83540 |
|
1,876 |
1,830 |
$9K |
| 83516 |
|
465 |
444 |
$9K |
| 87150 |
|
351 |
345 |
$9K |
| 83690 |
|
2,611 |
2,425 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,125 |
1,112 |
$9K |
| 85610 |
|
2,368 |
1,976 |
$8K |
| 87158 |
|
1,805 |
1,768 |
$8K |
| 73130 |
|
245 |
244 |
$8K |
| 80076 |
|
1,129 |
1,109 |
$8K |
| 85380 |
|
351 |
350 |
$8K |
| 77066 |
Tomosynthesis, mammo |
130 |
129 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,680 |
1,387 |
$7K |
| 86038 |
|
696 |
692 |
$7K |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
354 |
351 |
$7K |
| 73630 |
|
334 |
330 |
$7K |
| 81001 |
|
3,254 |
3,101 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
141 |
141 |
$7K |
| 87641 |
|
179 |
179 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
173 |
171 |
$7K |
| 85652 |
|
2,801 |
2,710 |
$7K |
| 82746 |
|
487 |
481 |
$7K |
| 82565 |
|
1,554 |
1,535 |
$6K |
| 73610 |
|
257 |
253 |
$6K |
| 87186 |
|
1,019 |
985 |
$6K |
| 76536 |
|
213 |
213 |
$6K |
| 97035 |
|
358 |
159 |
$6K |
| 86364 |
|
755 |
601 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
388 |
386 |
$6K |
| 82950 |
|
1,372 |
1,368 |
$6K |
| 84460 |
|
1,452 |
1,421 |
$6K |
| 77065 |
Tomosynthesis, mammo |
90 |
87 |
$6K |
| 86706 |
|
452 |
449 |
$6K |
| 0002A |
|
200 |
200 |
$5K |
| 86618 |
|
311 |
306 |
$5K |
| 73110 |
|
90 |
89 |
$5K |
| 86704 |
|
405 |
403 |
$5K |
| 90686 |
|
281 |
281 |
$5K |
| 84450 |
|
1,128 |
1,105 |
$5K |
| 88304 |
|
74 |
70 |
$5K |
| 94729 |
|
205 |
199 |
$5K |
| 84703 |
|
1,510 |
1,448 |
$4K |
| 73562 |
|
151 |
150 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
26 |
26 |
$4K |
| 84480 |
|
304 |
298 |
$4K |
| 84156 |
|
1,084 |
917 |
$4K |
| 82150 |
|
718 |
696 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
248 |
248 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
243 |
243 |
$4K |
| A9573 |
Injection, gadopiclenol, 1 ml |
93 |
55 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
39 |
39 |
$4K |
| 72141 |
|
16 |
15 |
$4K |
| 82977 |
|
793 |
742 |
$4K |
| 0001A |
|
203 |
203 |
$4K |
| 84520 |
|
1,005 |
995 |
$4K |
| 70491 |
|
14 |
14 |
$4K |
| 84132 |
|
789 |
776 |
$4K |
| 99442 |
|
41 |
39 |
$4K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
142 |
141 |
$3K |
| 80050 |
General health panel |
134 |
133 |
$3K |
| 94010 |
|
84 |
84 |
$3K |
| 70498 |
|
12 |
12 |
$3K |
| 86376 |
|
129 |
129 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
342 |
341 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,280 |
1,170 |
$3K |
| 84100 |
|
738 |
517 |
$2K |
| 84295 |
|
851 |
845 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
212 |
208 |
$2K |
| 84146 |
|
121 |
118 |
$2K |
| 84484 |
|
790 |
480 |
$2K |
| 82247 |
|
709 |
653 |
$2K |
| 85007 |
|
859 |
759 |
$2K |
| 83001 |
|
140 |
139 |
$2K |
| 99443 |
|
49 |
46 |
$2K |
| 73140 |
|
31 |
31 |
$2K |
| 83605 |
|
463 |
430 |
$2K |
| 81003 |
|
1,480 |
1,438 |
$2K |
| 87040 |
|
133 |
106 |
$2K |
| 97116 |
|
71 |
37 |
$2K |
| 84075 |
|
502 |
491 |
$2K |
| 0071A |
|
43 |
43 |
$2K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
27 |
27 |
$2K |
| 82040 |
|
466 |
386 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,479 |
1,315 |
$2K |
| 82947 |
|
555 |
551 |
$1K |
| 84466 |
|
76 |
73 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$1K |
| 80069 |
|
149 |
131 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$1K |
| 81002 |
|
821 |
747 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
454 |
371 |
$1K |
| 87505 |
|
15 |
12 |
$1K |
| 0072A |
|
27 |
27 |
$1K |
| 85730 |
|
260 |
258 |
$1K |
| 87070 |
|
124 |
123 |
$1K |
| 73030 |
|
55 |
53 |
$989.09 |
| 82670 |
|
41 |
41 |
$969.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
849 |
832 |
$939.60 |
| 86480 |
|
12 |
12 |
$899.50 |
| 84550 |
|
197 |
177 |
$836.89 |
| J2704 |
Injection, propofol, 10 mg |
1,186 |
1,168 |
$808.44 |
| 94060 |
|
24 |
24 |
$799.07 |
| 86800 |
|
65 |
65 |
$787.97 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,551 |
1,523 |
$686.78 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
114 |
98 |
$542.22 |
| 83020 |
|
40 |
40 |
$541.86 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,127 |
1,959 |
$538.25 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$530.98 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
61 |
61 |
$467.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,586 |
1,541 |
$398.01 |
| 99335 |
|
14 |
14 |
$374.91 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16 |
16 |
$367.64 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
26 |
26 |
$366.15 |
| 86431 |
|
64 |
64 |
$355.98 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,485 |
2,196 |
$313.74 |
| 76813 |
|
13 |
12 |
$280.80 |
| 72100 |
|
40 |
38 |
$276.50 |
| 82533 |
|
17 |
12 |
$273.82 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
30 |
26 |
$261.87 |
| 86696 |
|
12 |
12 |
$243.23 |
| 83615 |
|
45 |
40 |
$226.21 |
| 72110 |
|
12 |
12 |
$218.16 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
144 |
138 |
$207.64 |
| 84481 |
|
12 |
12 |
$205.60 |
| 86231 |
|
12 |
12 |
$168.57 |
| 82951 |
|
12 |
12 |
$163.32 |
| 82550 |
|
32 |
29 |
$153.66 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
115 |
113 |
$138.73 |
| 87205 |
|
46 |
46 |
$125.30 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
16 |
$121.14 |
| 72070 |
|
13 |
13 |
$99.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
40 |
40 |
$84.38 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
12 |
12 |
$64.17 |
| 86308 |
|
12 |
12 |
$60.60 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
73 |
67 |
$54.34 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
237 |
229 |
$51.83 |
| 82248 |
|
14 |
14 |
$44.12 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
20 |
20 |
$41.38 |
| 82952 |
|
12 |
12 |
$33.36 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
43 |
43 |
$32.36 |
| 84155 |
|
12 |
12 |
$30.55 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
92 |
74 |
$29.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$19.26 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
107 |
102 |
$14.64 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
37 |
37 |
$6.11 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
14 |
12 |
$0.71 |